Royal Bank of Canada’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-36,925
Closed -$138K 6814
2024
Q3
$138K Sell
36,925
-676
-2% -$2.53K ﹤0.01% 4676
2024
Q2
$211K Buy
37,601
+9,445
+34% +$53K ﹤0.01% 4349
2024
Q1
$147K Buy
28,156
+24,600
+692% +$128K ﹤0.01% 4508
2023
Q4
$19K Buy
3,556
+1,694
+91% +$9.05K ﹤0.01% 5802
2023
Q3
$29K Sell
1,862
-1,642
-47% -$25.6K ﹤0.01% 5555
2023
Q2
$68K Sell
3,504
-1,538
-31% -$29.8K ﹤0.01% 5170
2023
Q1
$143K Buy
5,042
+2,119
+72% +$60.1K ﹤0.01% 4513
2022
Q4
$85K Sell
2,923
-425
-13% -$12.4K ﹤0.01% 5112
2022
Q3
$88K Buy
3,348
+3,150
+1,591% +$82.8K ﹤0.01% 4909
2022
Q2
$9K Sell
198
-654
-77% -$29.7K ﹤0.01% 5970
2022
Q1
$42K Sell
852
-1,217
-59% -$60K ﹤0.01% 5718
2021
Q4
$106K Buy
2,069
+930
+82% +$47.6K ﹤0.01% 5368
2021
Q3
$64K Sell
1,139
-4,696
-80% -$264K ﹤0.01% 5498
2021
Q2
$250K Sell
5,835
-1,742
-23% -$74.6K ﹤0.01% 4414
2021
Q1
$317K Sell
7,577
-2,841
-27% -$119K ﹤0.01% 4102
2020
Q4
$486K Sell
10,418
-147
-1% -$6.86K ﹤0.01% 3676
2020
Q3
$448K Buy
10,565
+2,963
+39% +$126K ﹤0.01% 3511
2020
Q2
$364K Sell
7,602
-601
-7% -$28.8K ﹤0.01% 3594
2020
Q1
$377K Sell
8,203
-13,223
-62% -$608K ﹤0.01% 3415
2019
Q4
$1.29M Buy
21,426
+2,370
+12% +$142K ﹤0.01% 2733
2019
Q3
$1.08M Buy
19,056
+5,373
+39% +$304K ﹤0.01% 2784
2019
Q2
$763K Buy
13,683
+1
+0% +$56 ﹤0.01% 3038
2019
Q1
$690K Buy
13,682
+13,044
+2,045% +$658K ﹤0.01% 2994
2018
Q4
$26K Sell
638
-82
-11% -$3.34K ﹤0.01% 4746
2018
Q3
$50K Buy
720
+57
+9% +$3.96K ﹤0.01% 4641
2018
Q2
$50K Sell
663
-5,033
-88% -$380K ﹤0.01% 4577
2018
Q1
$301K Sell
5,696
-14,018
-71% -$741K ﹤0.01% 3478
2017
Q4
$1.05M Sell
19,714
-39,245
-67% -$2.1M ﹤0.01% 2599
2017
Q3
$3.52M Buy
58,959
+10,742
+22% +$641K ﹤0.01% 1834
2017
Q2
$3.81M Buy
48,217
+42,625
+762% +$3.36M ﹤0.01% 1737
2017
Q1
$464K Buy
5,592
+1,543
+38% +$128K ﹤0.01% 3127
2016
Q4
$321K Sell
4,049
-10,053
-71% -$797K ﹤0.01% 3435
2016
Q3
$987K Buy
14,102
+1,751
+14% +$123K ﹤0.01% 2503
2016
Q2
$479K Buy
12,351
+417
+3% +$16.2K ﹤0.01% 3117
2016
Q1
$484K Buy
11,934
+4,410
+59% +$179K ﹤0.01% 3084
2015
Q4
$667K Buy
7,524
+5,020
+200% +$445K ﹤0.01% 2881
2015
Q3
$186K Buy
2,504
+1,869
+294% +$139K ﹤0.01% 3817
2015
Q2
$51K Buy
635
+135
+27% +$10.8K ﹤0.01% 4723
2015
Q1
$21K Hold
500
﹤0.01% 4887
2014
Q4
$8K Buy
500
+200
+67% +$3.2K ﹤0.01% 5090
2014
Q3
$4K Hold
300
﹤0.01% 5134
2014
Q2
$4K Hold
300
﹤0.01% 5105
2014
Q1
$4K Buy
+300
New +$4K ﹤0.01% 5069